Moćko, P.; Śladowska, K.; Kawalec, P.; Babii, Y.; Pilc, A.
The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials. Biomedicines 2023, 11, 2636.
https://doi.org/10.3390/biomedicines11102636
AMA Style
Moćko P, Śladowska K, Kawalec P, Babii Y, Pilc A.
The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials. Biomedicines. 2023; 11(10):2636.
https://doi.org/10.3390/biomedicines11102636
Chicago/Turabian Style
Moćko, Paweł, Katarzyna Śladowska, Paweł Kawalec, Yana Babii, and Andrzej Pilc.
2023. "The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials" Biomedicines 11, no. 10: 2636.
https://doi.org/10.3390/biomedicines11102636
APA Style
Moćko, P., Śladowska, K., Kawalec, P., Babii, Y., & Pilc, A.
(2023). The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials. Biomedicines, 11(10), 2636.
https://doi.org/10.3390/biomedicines11102636